Synergistic Enhancement of siRNA Transfection by Hybrid Lipid−Trimethyl Chitosan Nanoparticles
Bioconjugate Chemistry · 02.11.2026
DOI: 10.1021/acs.bioconjchem.6c00382 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 02.11.2026. Verfasst von Leslie Vanessa Sanchez-Castillo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Materials Engineering, Faculty of Engineering, University of Alberta, 116 St & 85 Avenue, EdmontonAB T6G 2G6, Canada. Hauptthemen laut MEDLINE: RNA, Small Interfering, Chitosan, Nanoparticles, Transfection. Die Arbeit nennt 70 Literaturangaben. Gefördert von: Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
The clinical potential of RNA interference (RNAi) technologies, particularly siRNA-based therapeutics, remains limited by the need for safe, stable, and efficient delivery systems. Both lipid nanoparticles (LNPs) and chitosan-based carriers have demonstrated significant potential for nucleic acid delivery; however, each platform presents distinct limitations. LNPs may show limited mucosal retention and formulation instability, whereas trimethyl chitosan (TMC)-based systems often exhibit lower transfection efficiency despite their favorable stability and mucoadhesive properties. In this study, we developed a hybrid delivery system combining LNPs with a polymeric matrix composed of N,N,N-trimethyl chitosan (TMC) and the helper components dextran sulfate (DS), tripolyphosphate (TPP), and hyaluronic acid (HA). The resulting hybrid nanoparticles exhibited reduced hydrodynamic diameters relative to TMC-based nanoparticles, low polydispersity, and composition-dependent changes in surface charge and structural organization. Fluorescence-based analysis further demonstrated high apparent siRNA association and increased resistance to decomplexation in the complete hybrid formulations. Electron microscopy revealed a more complex hybrid architecture and interparticle organization compared with the parent LNPs. Using a stable 293T-eGFP cell model, the hybrid system achieved high gene silencing (∼87%) at optimized TMC/siRNA weight ratios, outperforming polymer-only and lipid-only formulations under selected conditions. Confocal and live-cell fluorescence imaging confirmed efficient intracellular uptake and trafficking through acidic endolysosomal compartments, while cytotoxicity assays indicated high biocompatibility at moderate TMC concentrations. Short-term stability studies further showed that incorporation of the TMC-based matrix preserved transfection performance after 5 days of storage. Overall, the hybrid formulation combines the efficient intracellular delivery characteristics of LNPs with the structural and cargo-retention advantages of TMC-based systems, supporting its potential as a versatile platform for siRNA delivery and gene-silencing applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Materials Engineering, Faculty of Engineering, University of Alberta, 116 St & 85 Avenue, EdmontonAB T6G 2G6, Canada.
- Human Health Therapeutics, National Research Council Canada, Ottawa, OntarioK1A 0R6, Canada.
ORCID-Profile: Ravin Narain
Förderung
- Canada Foundation for Innovation
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Sanchez-Castillo, L. V., Agbayani, G., Jia, Y., & Narain, R. (2026). Synergistic Enhancement of siRNA Transfection by Hybrid Lipid−Trimethyl Chitosan Nanoparticles. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.6c00382
Vancouver
Sanchez-Castillo LV, Agbayani G, Jia Y, Narain R. Synergistic Enhancement of siRNA Transfection by Hybrid Lipid−Trimethyl Chitosan Nanoparticles. Bioconjugate Chemistry. 2026. doi:10.1021/acs.bioconjchem.6c00382
BibTeX
@article{SanchezCastillo2026,
author = {Sanchez-Castillo, Leslie Vanessa and Agbayani, Gerard and Jia, Yimei and Narain, Ravin},
title = {Synergistic Enhancement of siRNA Transfection by Hybrid Lipid−Trimethyl Chitosan Nanoparticles},
journal = {Bioconjugate Chemistry},
year = {2026},
doi = {10.1021/acs.bioconjchem.6c00382}
}
EUVIMED